Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Follow-Up Questions
Eden Research PLC 的 CEO 是谁?
Mr. Sean Smith 是 Eden Research PLC 的 Chief Executive Officer,自 2014 加入公司。
EDNSF 股票的价格表现如何?
EDNSF 的当前价格为 $0,在上个交易日 decreased 了 0%。
Eden Research PLC 的主要业务主题或行业是什么?
Eden Research PLC 属于 Chemicals 行业,该板块是 Materials
Eden Research PLC 的市值是多少?
Eden Research PLC 的当前市值是 $0
Eden Research PLC 是买入、卖出还是持有?
据华尔街分析师称,共有 3 位分析师对 Eden Research PLC 进行了分析师评级,包括 2 位强烈买入,2 位买入,1 位持有,0 位卖出,以及 2 位强烈卖出